Moreover, rotenone administration results in induction of oxidative stress and neuroinflammation subsequent to activation of microglia, astrocytes and the inhibition of proteosomal activity, along with the accumulation of alpha-synuclein positive nigral inclusions, a hallmark of PD [16]. The gene discussed is SNCA; the disease is Parkinson disease.